BridgeBio Pharma (BBIO) total assets

Total assets · fiscal 2025
$936.03M

BridgeBio Pharma (BBIO) had total assets of $936.03M at the end of fiscal 2025 (December 31, 2025). That is 1.8% higher than the $919.34M of fiscal 2024. Figures as of 18 Nov 2026, 09:55 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$936.03M
Change on fiscal 2024
+1.8%
Growth, 5 years
+5.9% a year
Highest on record
$1.01Bfiscal 2021
Lowest on record
$464.94Mfiscal 2018
Fiscal years on record
82018–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

BridgeBio Pharma total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 5.9% a year. Across the 8 fiscal years on record (2018–2025), the highest was $1.01B in fiscal 2021 and the lowest $464.94M in fiscal 2018.

History · 8 fiscal years

Total assets by fiscal year

BridgeBio Pharma total assets, year by year

BridgeBio Pharma (BBIO) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$936.03M 1.8% up
2024$919.34M 68.3% up
2023$546.38M 12.3% down
2022$623.04M 38.5% down
2021$1.01B 43.9% up
2020$703.59M 11.4% up
2019$631.68M 35.9% up
2018$464.94M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of BridgeBio Pharma and comparable companies
CompanyTotal assetsFiscal year
ICON ICLR$16.27B2025
Jazz Pharmaceuticals JAZZ$11.66B2025
Solventum SOLV$14.29B2025
BridgeBio Pharma BBIO$936.03M2025
Summit Therapeutics SMMT$751.18M2025
Glaukos GKOS$893.49M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BBIO

BridgeBio Pharma, figure by figure

BridgeBio Pharma (BBIO) overview: price, valuation and scorecardAll health care companies by market value

BridgeBio Pharma total assets: questions and answers

How large are BridgeBio Pharma's total assets?

BridgeBio Pharma (BBIO) had total assets of $936.03M at the end of fiscal 2025 (December 31, 2025). That is 1.8% higher than the $919.34M of fiscal 2024.

What is the growth rate of BridgeBio Pharma's total assets?

Over the five fiscal years to 2025 total assets grew at a compound 5.9% a year.

What are the highest and lowest total assets figures on record for BridgeBio Pharma?

Across the 8 fiscal years on record (2018–2025), the highest was $1.01B in fiscal 2021 and the lowest $464.94M in fiscal 2018.

How is BridgeBio Pharma's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest. For BridgeBio Pharma it is on record here for 8 fiscal years, 2018 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “BridgeBio Pharma (BBIO) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/BBIO/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.